Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edb72286e25757f3d54dcb5d15c9796b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55544 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-64 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 |
filingDate |
2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9ad84c25d42232c10a68d430e9674d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8026bacb20a0a04aa45433d0f6763074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddc01cf1ed276b3b27cc63d808c7f984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e6ecde17c91c244df9550da8f76ddd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acc732c9842361e7e935287a47bfe281 |
publicationDate |
2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2890703-A1 |
titleOfInvention |
Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics |
abstract |
The present invention relates to the synthesis of GPI-related surface antigens of the parasite Toxoplasma gondii (T. gondii) and the resulting products obtained. These synthetic compounds are suitable for diagnosis of toxoplasmosis, as well as vaccine against toxoplasmosis, a diseases caused by infection with T. gondii. |
priorityDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |